Introducing our founder, Damien Bové
Leading ADACT’s team of experts is Damien Bové, BSc (Sci. Hons), MSc (Sci. Open), ICR.
Damien Bové, BSc (Sci. Hons), MSc (Sci. Open), ICR
Damien brings an entrepreneurial and creative spirit to his role as Chief Regulator Officer and Scientific Advisor. He leads ADACT’s team of scientists and global regulatory compliance experts for the vaping, CBD, hemp and traditional herbal medicines (THRs) industries. Based at ADACT’s state-of-the-art laboratory in Yorkshire, England, Damien also finds time to travel to industry events around the world.
Studies
- 1996 to 2000 - Pharmaceutical Sciences BSc (Hons) at University of Bradford
- 2001 to 2003 - Frontiers of Medical Science MSc at Open University
Standards committees
- 2019 to present - British Standards Institute (BSI): Committee member for Electronic Cigarettes and E-liquids standards (EN, CEN, ESO)
Professional career
- 1998 to 1999 - Academic Liaison (SmithKline Beecham)
- 2000 to 2001 - Research Assistant to Research Associate (GlaxoSmithKline)
- 2001 to 2002 - Research Assistant to Commercial Consultant (Covance)
- 2002 to 2003 - Research Assistant to Director of Emergent Product Services (Covance)
- 2004 to present - Independent consultant (Medical Technologies)
- 2009 to 2013 - Director and Regulatory Officer (IDA)
- 2012 to present: Chief Regulatory Officer (ADACT Medical Ltd)
- 2013 to 2015 - Director of Product Development (Yorkshire Biotec)
- 2014 to 2016 - Director Innovation Centre (The HUB) (Charnwood Biomedical Campus)
Guest speaker / panelist
- 16 July 2018 - All-party parliamentary group to discuss vaping regulation post-Brexit
- 7 November 2018 - Regulation and compliance at CTAUK AGM
- 25 April 2019 - Novel Foods, Hemp and CBD Expo at NEC Birmingham
- 9 May 2019 - Future of vape regulations and CBD at UKVIA
- 11 July 2019 - Cannabidoil: Food Supplements Special Interest Group with Consult2deliver
- 18 July 2019 - Board meeting, campaigning for fair and appropriate regulations with UKVIA
- 28 September 2019 - CEN standards meeting for chemicals in vaping in Sicily
- 2 October 2019 - ISO standards representing UKVIA
- 28 October 2019 - PMTA public meeting with U.S. Food and Drug Administration (FDA)
Further training
- 2000 - Clinical Research Overview (Covance)
- 2003 - Advanced Issues in Clinical Research (Imperial College London)
- 2006 - The Lifecycle of NHS Clinical Trials (ICR)
- 2010 - Advanced Therapy Regulations
- 2014 - Cancer Innovation Exchange (East Midlands Academic Health Science Network)
- 2014 - Module 3 dossiers for Traditional Herbal Medicinal Products (British Herbal Medicine Association)
- 2016 - Regulation of Herbal Medicines (Callisto Consulting Ltd)
Memberships
- 2003 to 2004 - Member of the Health Economics Study Group
- 2007 to present - The Institute of Clinical Research (ICR), Registered Member
- 2017 to present - UK Vaping Industry Association (UKVIA), Full Member
- 2019 to present - Information Commissioner’s Office (ICO) members
- 2019 to present - The Medical Cannabis Clinicians Society (MCCS) members
- 2020 to present - Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA) members
- 2021 to present - British Herbal Medicine Assocation (BHMA) members
Other work
- 2015 to 2018 - Regulatory Officer, European Electronic Cigarette Business Association (ECCBA)
- 2000 to present - Works with the MHRA, FDA, Health Canada, EMEA and UKVIA amongst others
Peer review
- 2015 to present - Cell and Gene Therapy Insights